CAS: 308242-62-8 - Remimazolam
Fórmula:C21H19BrN4O2
InChI:InChI=1S/C21H19BrN4O2/c1-13-12-24-21-17(7-9-19(27)28-2)25-20(16-5-3-4-10-23-16)15-11-14(22)6-8-18(15)26(13)21/h3-6,8,10-12,17H,7,9H2,1-2H3/t17-/m0/s1
Clave InChI:InChIKey=CYHWMBVXXDIZNZ-KRWDZBQOSA-N
SMILES:O=C(OC)CCC1N=C(C=2N=CC=CC2)C=3C=C(Br)C=CC3N4C1=NC=C4C
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Remimazolam REF: TR-R143600CAS: 308242-62-8 | - - - | 244,00 €~1.658,00 € | Mié 12 Jun 24 |
 | Remimazolam REF: 3D-FR181797CAS: 308242-62-8 | Min. 95% | A consultar | Jue 13 Jun 24 |
| Methyl 3-(8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo(1,2-A)(1,4)benzodiazepin-4-yl)propanoate REF: 3D-IMA24262CAS: 308242-62-8 | Min. 95% | A consultar | Mar 16 Jul 24 |
Remimazolam
Producto controladoCAS:308242-62-8
Applications Remimazolam, is a drug and benzodiazepine derivative. It is used as an alternative to …
Fórmula:
C21H19BrN4O2
Forma y color:
Neat
Peso molecular:
439.31
Ref: TR-R143600
| 1mg | 244,00 € | |
| 5mg | 1.027,00 € | |
| 10mg | 1.658,00 € |
Entrega estimada en Estados Unidos, el Miércoles 12 de Junio de 2024
Remimazolam
Producto controladoCAS:308242-62-8
Please enquire for more information about Remimazolam including the price, delivery time and more detailed …
Fórmula:
C21H19BrN4O2
Pureza:
Min. 95%
Peso molecular:
439.3 g/mol
Ref: 3D-FR181797
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Jueves 13 de Junio de 2024
Methyl 3-(8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo(1,2-A)(1,4)benzodiazepin-4-yl)propanoate
CAS:308242-62-8
Please enquire for more information about Methyl 3-(8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo(1,2-A)(1,4)benzodiazepin-4-yl)propanoate including the price, delivery time and more …
Fórmula:
C21H19BrN4O2
Pureza:
Min. 95%
Peso molecular:
439.3 g/mol
Ref: 3D-IMA24262
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 16 de Julio de 2024
